共 48 条
- [3] IV FERRIC CARBOXYMALTOSE (FCM) IS A CONVENIENT AND WELL-TOLERATED FIRST-LINE THERAPY FOR THE TREATMENT OF ANAEMIA IN PATIENTS WITH IRON DEFICIENCY AND NON-DIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE (ND-CKD): RESULTS OF THE RANDOMISED FIND-CKD STUDY [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 21 - 21
- [4] Hepcidin Response to Iron Therapy in Patients with Non-Dialysis Dependent CKD: An Analysis of the FIND-CKD Trial [J]. PLOS ONE, 2016, 11 (06):